New research indicates certain blood markers may signal a higher risk of colorectal cancer in younger adults. Adults under 45 with lower levels of specific liver enzymes were found to be more likely to develop this type of cancer.

Further details on this analysis are available, including the specific enzymes involved. The findings were released by Epic Research, a company owned by a health-care software firm.

The connection between these enzymes and cancer risk is noteworthy, as it differs from typical clinical observations. For more information on this study, readers can consult the original report.